UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Eli Lilly Korea launches migraine prevention drug
Eli Lilly said that it has officially launched Emgality, a migraine prevent...
by Lee Han-soo
|
2019-12-12 15:28
라인
Sanofi releases new meta-analysis data for diabetes treatment Soliqua
Sanofi said that it has presented the results of a new network meta-analysi...
by Lee Han-soo
|
2019-12-12 15:01
라인
Hanmi unveils new data at American Society of Hematology
Hanmi Pharmaceutical said that it has presented clinical trial results for ...
by Lee Han-soo
|
2019-12-12 14:17
라인
Bayer Korea names Freda Lin as new president
Bayer Korea announced that it has appointed Freda Lin as its new president,...
by Lee Han-soo
|
2019-12-12 14:16
라인
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
SK Bioscience said its Sky Varicella has become the world's second chic...
by Lee Han-soo
|
2019-12-11 15:30
라인
ABL Bio unveils new bispecific antibody at US meet
ABL Bio said that it has introduced a B-cell maturation antigen (BCMA)x4-1B...
by Lee Han-soo
|
2019-12-10 18:12
라인
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
Hanmi Pharmaceutical and Sanofi are looking for a new partner to commercial...
by Lee Han-soo
|
2019-12-10 11:43
라인
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
Samyang Biopharm USA said Tuesday it has signed a deal to develop a new imm...
by Lee Han-soo
|
2019-12-10 11:43
라인
AbbVie's releases new data for chronic lymphocytic leukemia treatment
AbbVie has presented new long-term data, further supporting the sustained c...
by Lee Han-soo
|
2019-12-09 17:42
라인
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Medipost said Japan's Ministry of Health, Labour and Welfare has approv...
by Lee Han-soo
|
2019-12-09 16:15
라인
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
As preannounced by Biogen in October, its Alzheimer's drug candidate ad...
by Kim Yun-mi
|
2019-12-09 14:39
라인
New MSD labor union launched with fresh resolve
A new MSD Korea labor union has kicked off. The new union consists of emplo...
by Jeong Sae-im
|
2019-12-09 14:37
라인
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
Gemvax & Kael said that it presented the results of phase 2 clinical trial ...
by Lee Han-soo
|
2019-12-06 17:06
라인
AbbVie’s Venclexta nears insurance benefit
AbbVie Korea’s Venclexta Tab. (ingredient: venetoclax), a drug for recurren...
by Kim Eun-young
|
2019-12-06 16:35
라인
Syntekabio, CHA Hospital to co-develop immunotherapy
Syntekabio said that it will develop immunotherapy agents jointly with CHA ...
by Lee Han-soo
|
2019-12-06 16:32
라인
Medpacto vows to become global company specializing in biomarker-based drugs
Medpacto, a subsidiary of Theregen ETEX, plans to develop Vactosertib, an i...
by Lee Han-soo
|
2019-12-06 15:03
라인
Petitioner demands broader benefit for ovarian cancer drug Zejula
The government granted insurance benefit to Takeda's ovarian cancer tre...
by Song Soo-youn
|
2019-12-06 15:02
라인
China OKs Humedix's hyaluronic acid filler
Humedix said that China's National Medical Products Administration (NMP...
by Lee Han-soo
|
2019-12-06 15:02
라인
‘Lynparza raises value of precision medicine as anticancer treatment’
AstraZeneca’s Lynparza (ingredient: olaparib), the first PARP (poly ADP rib...
by Kim Yun-mi
|
2019-12-05 16:05
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
Roche Diabetes Care emphasized the importance of “integrated personalized d...
by Park Gi-taek
|
2019-12-05 13:01
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top